Training worship for Data Collectors for Pharmaceutical Sector Assessment Survey held
Islamabad, September 17, 2014 (PPI-OT): – WHO in collaboration with DRAP organized a three day training workshop for Data Collectors for Pharmaceutical Sector Assessment Survey (PSAS) “Level II”, at WHO Country office September 15-17 2014.
– WHO in collaboration with the Drug Regulatory Authority of Pakistan (DRAP), Ministry of National Health Services, Regulation and Coordination (MONHSRC) have built the consensus to conduct the Pharmaceutical Sector Assessment Survey (PSAS) Level II in 2014. Pakistan.
Since 2002, a total of 11 EMR countries have conducted pharmaceutical sector Level II surveys. In Pakistan it was earlier conducted in 2007 and now it is the time to update this information in view of changing scenario.
– WHO has developed these tools to measure the pharmaceutical sector performance and systematically monitor the progress of efforts to improve access to essential medicines, availability, use and compare situations in different health facilities at different levels of health care.
– A comprehensive assessment of the pharmaceutical sector helps to determine what the gaps are in order to design effective interventions and allows evaluation of the impact of interventions over time.
– Pakistan is a country with double burden of communicable diseases combined with maternal and perinatal conditions and increasing trends in non-communicable diseases. Country is having poor maternal and neonatal health indicators like 89 deaths /1,000 live births entailing that (01) in every 11 children born in Pakistan die before reaching their fifth birthday. The infant mortality rate is again alarming is 74 deaths per 1,000 live births.(PSLM2012-13)
– Medicines account for a substantial 43 percent of total household health expenditure in Pakistan while total health expenditures 64 percent are borne by households mainly through out of pocket payments (NHA. (2009) National Health Accounts).
– Pakistan has vast primary health care system. Assessing the performance of the public health service in is critical. Availability of medicines is vital to ensure PHC utilization, Medicines non-availabilty leads to underutilization of public primary health care facilities, the gap exists between rural and urban use of health facilities (World Bank, 2010).
– The aim of training is to build national capacity on conducting, assessing, monitoring and evaluating country pharmaceutical situations which could help to plan policies to address issues of access and rational use of medicines.
– The results of assessment will serve as a monitoring mechanism to assess pharmaceutical sector performance. The information thus collected will help and guide to National and provincial health authorities in revising National health policy, provincial health strategies and medicine policies affecting access to medicines.
– This will also help governments to focus on identified priorities, advocacy plans and initiate information campaigns. As evident access and availability to quality medicines is vital for success of all health interventions which ultimately linked with improvement in health related Millennium development goals (MDGS).
For more information, contact:
World Health Organization (WHO)
The post Training worship for Data Collectors for Pharmaceutical Sector Assessment Survey held appeared first on AsiaNet-Pakistan.